JPS5191314A - - Google Patents

Info

Publication number
JPS5191314A
JPS5191314A JP51000126A JP12676A JPS5191314A JP S5191314 A JPS5191314 A JP S5191314A JP 51000126 A JP51000126 A JP 51000126A JP 12676 A JP12676 A JP 12676A JP S5191314 A JPS5191314 A JP S5191314A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51000126A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS5191314A publication Critical patent/JPS5191314A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP51000126A 1975-01-06 1976-01-06 Pending JPS5191314A (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH7175 1975-01-06
CH1474775 1975-11-13

Publications (1)

Publication Number Publication Date
JPS5191314A true JPS5191314A (enExample) 1976-08-10

Family

ID=25683420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51000126A Pending JPS5191314A (enExample) 1975-01-06 1976-01-06

Country Status (10)

Country Link
JP (1) JPS5191314A (enExample)
AU (1) AU499139B2 (enExample)
BE (1) BE837294A (enExample)
CA (1) CA1059914A (enExample)
DE (1) DE2600021A1 (enExample)
FR (1) FR2296415A1 (enExample)
GB (1) GB1500300A (enExample)
IE (1) IE42765B1 (enExample)
IL (1) IL48787A (enExample)
NL (1) NL7600047A (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55129222A (en) * 1979-02-02 1980-10-06 Orion Yhtymae Oy Manufacture of tablet
JPS56103110A (en) * 1980-01-11 1981-08-18 Boots Co Ltd Sustained release medicinal composition
JP2013100365A (ja) * 2006-07-25 2013-05-23 Kowa Co 糖衣製剤およびその製造方法
JP2013231080A (ja) * 2006-05-22 2013-11-14 Biohit Oyj 胃内でアセトアルデヒドを結合するための組成物および方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731339A (en) * 1995-04-28 1998-03-24 Zonagen, Inc. Methods and formulations for modulating the human sexual response

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL51480C (enExample) *
FR1013681A (fr) * 1947-01-31 1952-08-01 Ciba Geigy Nouvelles imidazolines et procédé pour leur fabrication

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55129222A (en) * 1979-02-02 1980-10-06 Orion Yhtymae Oy Manufacture of tablet
JPS56103110A (en) * 1980-01-11 1981-08-18 Boots Co Ltd Sustained release medicinal composition
JP2013231080A (ja) * 2006-05-22 2013-11-14 Biohit Oyj 胃内でアセトアルデヒドを結合するための組成物および方法
JP2013100365A (ja) * 2006-07-25 2013-05-23 Kowa Co 糖衣製剤およびその製造方法
JP2014221847A (ja) * 2006-07-25 2014-11-27 興和株式会社 糖衣製剤およびその製造方法

Also Published As

Publication number Publication date
IL48787A (en) 1978-09-29
NL7600047A (nl) 1976-07-08
FR2296415A1 (fr) 1976-07-30
IE42765B1 (en) 1980-10-08
BE837294A (fr) 1976-07-05
AU499139B2 (en) 1979-04-05
AU1000176A (en) 1977-07-14
GB1500300A (en) 1978-02-08
IL48787A0 (en) 1976-03-31
IE42765L (en) 1976-07-06
FR2296415B1 (enExample) 1978-08-18
CA1059914A (en) 1979-08-07
DE2600021A1 (de) 1976-07-15

Similar Documents

Publication Publication Date Title
FR2324030B1 (enExample)
FR2296415B1 (enExample)
JPS5512871B2 (enExample)
JPS5631772B2 (enExample)
JPS5227522U (enExample)
JPS5282172U (enExample)
JPS5191711U (enExample)
JPS5267969U (enExample)
CH600382A5 (enExample)
CH604187A5 (enExample)
CH586595A5 (enExample)
CH593408A5 (enExample)
CH601833A5 (enExample)
CH588401A5 (enExample)
CH596119A5 (enExample)
CH597750A5 (enExample)
CH593855A5 (enExample)
BG22925A1 (enExample)
CH604739A5 (enExample)
CH599899A5 (enExample)
CH606522A5 (enExample)
CH595519A5 (enExample)
BG21450A1 (enExample)
CH590460A5 (enExample)
CH606712A5 (enExample)